Comparative analysis of the quality of life among different retinal diseases

• Published in: Archivos de la Sociedad Española de Oftalmología (English ed.) 2023-11, Vol.98 (11), p.633-639
• Main Authors: Fernández-Vigo, J.I., Blanco-Darriba, D., Etxabe-Avila, H., Montolío-Marzo, E., Robles-Amor, P., Escobar-Moreno, M.J., Burgos-Blasco, B.
• Format: Article
• Language: English
• Subjects: Age-related macular degeneration; Calidad de vida; Central serous chorioretinopathy; Coriorretinopatía serosa central; Degeneración macular asociada a la edad; Diabetic retinopathy; Enfermedades retinianas; Quality of life; Retinal diseases; Retinopatía diabética
• ISSN: 2173-5794; 2173-5794
• DOI: 10.1016/j.oftale.2023.07.007

To assess the impact on the quality of life (QoL) among different retinal diseases such as diabetic macular edema (DME), retinal vein occlusion (RVO), pathologic myopia (PM), neovascular age-related macular degeneration (nAMD) and central serous chorioretinopathy (CSC). A cross-sectional study was carried out in 241 patients, affected by DME (n=44), RVO (n=41), PM (n=34) and nAMD (n=85) receiving intravitreal injections due to the presence of macular edema or choroidal neovascularization. The CSC patients included (n=37) were candidates for laser treatment. The patients included completed the National Eye Visual Functioning Questioning-25 (NEI VFQ-25). Best eye visual acuity (BEVA) was recorded using the Early Treatment Diabetic Retinopathy Study (ETDRS) scale. There were significant differences between subgroups for all the domains, except for the general vision in which all scores among diseases ranged from 40.7 to 45.2 out of 100 (P=.436), despite the difference in BEVA (CSC: 86.3±11.9; RVO: 78.5±15.5, DME: 73.3±15.2, nAMD: 72.9±12.6 and PM: 68.5±18.1 letters respectively; P